Effect of Corn Silk Tea on Hypertension

NCT06624423•Pir Mehr Ali Shah Arid Agriculture University

Summary

Subjects having hypertension were divided into 3 groups. one control and two experimental who were provided with 2g and 4g of corn silk tea twice per day for 12 weeks.

Eligibility

Age

30 - 60 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Subjects with Hypertension both male and female Subjects above age 30 years
•\-

Exclusion Criteria

•Subjects below age 30 years Pregnant and Lactating women Subjects with no co morbidities

Locations (1)

Institute of Food and Nutritional Sciences

Rawalpindi, Punjab Province, Pakistan

Key Dates

Start Date

December 1, 2023

Primary Completion Date

March 1, 2024

Completion Date

May 10, 2024

Last Updated

October 3, 2024

Enrollment

ACTUAL participants

Conditions

Hypertension

Interventions

corn silk tea

OTHER

Natural History of Noncirrhotic Portal Hypertension

NCT02417740

Cystic FibrosisImmunologic Deficiency Syndrome+3 more

View study

RECRUITINGPHASE2

A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489

NCT07073820

Pulmonary Hypertension

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 3, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Effect of Corn Silk Tea on Hypertension

Inclusion Criteria

Exclusion Criteria

Natural History of Noncirrhotic Portal Hypertension

A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489

Homocysteine and Early Diastolic Dysfunction in Newly Diagnosed Hypertension

Mobile Cued Adherence Therapy (mCAT) for Blood Pressure Medication

Penn Medicine Healthy Heart

Preliminary Human Trials of F230 Tablets